Back to search

Article

A low dose of naloxone mitigates autoimmune hepatitis by regulating TLR4/NF-κB and Nrf2/HO-1 signaling pathways

2023-05-04

Abstract excerpt

<title>Abstract</title> <p>Naloxone is a non-selective opiate receptor antagonist that is mainly used in the management of opiate addiction. Previously, naloxone has been shown to have anti-inflammatory and antioxidant properties. A popular and well-known animal model of autoimmune hepatitis that closely matches the pathogenic changes that take place in humans is the Concanavalin A (Con A) model. The present stud...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
06c81aa1-8db0-5831-8493-b3d7dd92f551
DOI
10.21203/rs.3.rs-2873574/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A low dose of naloxone mitigates autoimmune hepatitis by regulating TLR4/NF-κB and Nrf2/HO-1 signaling pathwaysDOI 10.21203/rs.3.rs-2873574/v1
Select a neighboring publication to make it the new centre.